Literature DB >> 16127357

Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000.

Adnan I Qureshi1, M Fareed K Suri, Jawad F Kirmani, Afshin A Divani.   

Abstract

BACKGROUND: The Seventh Report of the Joint National Committee (JNC-7) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure provided a new classification of blood pressure for adults aged to guide screening and treatment efforts. MATERIAL/
METHODS: Using the new classification, we examined trends and prevalence of pre-hypertension (120-139/80-89 mm Hg), stage 1 hypertension (140-159/90-99 mm Hg), and stage 2 hypertension (> or = 160/100 mm Hg) in a nationally representative sample of the United States population. We analyzed 4115 adult persons from 1999 and 2000 National Health and Nutrition Examination Survey (NHANES), 20,322 persons from NHANES II (1976-1980) and 30,818 persons from NHANES III (1988-1992).
RESULTS: In the United States population aged 20 or greater, we found that an estimated 41.9 million men and 27.8 million women have pre-hypertension, 12.8 million men and 12.2 million women have stage 1 hypertension, and 4.1 million men and 6.9 million women have stage 2 hypertension. Age- and sex-adjusted rates of pre-hypertension increased among non-Hispanic White, African American, and Hispanic persons between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 1 hypertension increased among Hispanics between 1988-1992 and 1999-2000. Age- and sex-adjusted rates of stage 2 hypertension decreased among non-Hispanic Whites between 1988-1992 and 1999-2000, but were unchanged for African American and Hispanic persons.
CONCLUSIONS: With over a 100 million persons with pre-hypertension or hypertension in the United States, a renewed effort directed towards screening, education, and treatment is required, particularly in the Hispanic population.

Entities:  

Mesh:

Year:  2005        PMID: 16127357

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  50 in total

1.  Immediate effects of upper thoracic spine manipulation on hypertensive individuals.

Authors:  John Ward; Ken Tyer; Jesse Coats; Gabbrielle Williams; Kristina Kulcak
Journal:  J Man Manip Ther       Date:  2015-02

Review 2.  Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review.

Authors:  Ina U Park; Anne L Taylor
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

3.  Prehypertension: detection, evaluation, and management.

Authors:  Ross Pacini; Dhaval R Patel; Venkata Bavikati; Laurence S Sperling
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-08

Review 4.  Vascular compliance in hypertension: therapeutic implications.

Authors:  Ho Won Lee; Jocelyn Karam; Babar Hussain; Nathaniel Winer
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

5.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

6.  Endothelial-dependent flow-mediated dilation in African Americans with masked-hypertension.

Authors:  Praveen Veerabhadrappa; Keith M Diaz; Deborah L Feairheller; Katie M Sturgeon; Sheara T Williamson; Deborah L Crabbe; Abul M Kashem; Michael D Brown
Journal:  Am J Hypertens       Date:  2011-06-16       Impact factor: 2.689

Review 7.  Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association.

Authors:  Carlos J Rodriguez; Matthew Allison; Martha L Daviglus; Carmen R Isasi; Colleen Keller; Enrique C Leira; Latha Palaniappan; Ileana L Piña; Sarah M Ramirez; Beatriz Rodriguez; Mario Sims
Journal:  Circulation       Date:  2014-07-14       Impact factor: 29.690

8.  Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users.

Authors:  Alyce S Adams; Connie Uratsu; Wendy Dyer; David Magid; Patrick O'Connor; Arne Beck; Melissa Butler; P Michael Ho; Julie A Schmittdiel
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

9.  Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study.

Authors:  Pascal L Kingah; Hung N Luu; Kelly A Volcik; Alanna C Morrison; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

10.  Should we screen for masked hypertension in patient with vascular disease?

Authors:  Pascal Delsart; Philippe Marboeuf; Cedric Delhaye; Gilles Lemesle; Claire Mounier-Vehier
Journal:  Vasc Health Risk Manag       Date:  2010-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.